bioLytical Laboratories Inc:企業の製品パイプライン分析

【英語タイトル】bioLytical Laboratories Inc - Product Pipeline Analysis, 2020 Update

GlobalDataが出版した調査資料(GDME15380PD)・商品コード:GDME15380PD
・発行会社(調査会社):GlobalData
・発行日:2021年1月
・ページ数:30
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・産業分野:Medical Devices
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD1,500 ⇒換算¥222,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD2,250 ⇒換算¥333,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

Summary
bioLytical Laboratories Inc (bioLytical) operates as a medical device company that develops and manufactures HIV diagnostic products. The company provides products such as insti HIV-1 and HIV-2 antibody test and insti HIV-1 and HIV-2 test controls. Its product line offers test result that translates into a value proposition. bioLytical provides insti kit which is a rapid antibody test, that detects antibodies of human immunodeficiency virus type one and type two in human whole blood, fingerstick blood, serum and plasma, among others. The company caters tests for diseases such as hepatitis C, Ebola, R and D programs, patients, healthcare professionals, payers, public health organizations, and others. It provides customer care services and markets its products through distributors in Canada and India. bioLytical is headquartered in Richmond, British Columbia, Canada.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company bioLytical Laboratories Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
bioLytical Laboratories Inc Company Overview
bioLytical Laboratories Inc Company Snapshot
bioLytical Laboratories Inc Pipeline Products and Ongoing Clinical Trials Overview
bioLytical Laboratories Inc – Pipeline Analysis Overview
bioLytical Laboratories Inc – Key Facts
bioLytical Laboratories Inc – Major Products and Services
bioLytical Laboratories Inc Pipeline Products by Development Stage
bioLytical Laboratories Inc Pipeline Products Overview
INSTI COVID-19 Antibody Test
INSTI COVID-19 Antibody Test Product Overview
INSTI Ebola Test
INSTI Ebola Test Product Overview
INSTI HIV Self Test
INSTI HIV Self Test Product Overview
INSTI Test – Chikungunya
INSTI Test – Chikungunya Product Overview
INSTI Test – Dengue
INSTI Test – Dengue Product Overview
INSTI Test – Hepatitis C
INSTI Test – Hepatitis C Product Overview
Zika/Flavivirus Test
Zika/Flavivirus Test Product Overview
bioLytical Laboratories Inc – Key Competitors
bioLytical Laboratories Inc – Key Employees
bioLytical Laboratories Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
bioLytical Laboratories Inc, Recent Developments
Sep 19, 2019: INSTI now available for expanded point-of-care use in Canada
Aug 08, 2019: HIV Self-testing Trial Begins in Canada
Feb 21, 2019: bioLytical Laboratories earns MDSAP certification, highest quality standard in medical device industry
Nov 28, 2018: INSTI HIV Self Test earns WHO prequalification status for home testing
Nov 24, 2017: VANC Pharmaceuticals Plans to Launch INSTI HIV Test with United Pharma Group on World AIDS Day
Jul 28, 2017: INSTI HIV Self Test detects HIV two weeks sooner than other brands
Jul 28, 2017: Instant HIV home test launched in the Netherlands
Jul 27, 2017: INSTI HIV Self Test Demonstrates High User Acceptance in Kenya Study
Jul 06, 2017: INSTI HIV Self Test Receives Global Fund Classification for Procurement
May 17, 2017: VANC Pharmaceuticals Announces Canadian Distribution Agreement for INSTI HIV-1/HIV-2 Antibody Test
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List of Tables
bioLytical Laboratories Inc Pipeline Products and Ongoing Clinical Trials Overview
bioLytical Laboratories Inc Pipeline Products by Equipment Type
bioLytical Laboratories Inc Pipeline Products by Indication
bioLytical Laboratories Inc, Key Facts
bioLytical Laboratories Inc, Major Products and Services
bioLytical Laboratories Inc Number of Pipeline Products by Development Stage
bioLytical Laboratories Inc Pipeline Products Summary by Development Stage
INSTI COVID-19 Antibody Test - Product Status
INSTI COVID-19 Antibody Test - Product Description
INSTI Ebola Test - Product Status
INSTI Ebola Test - Product Description
INSTI HIV Self Test - Product Status
INSTI HIV Self Test - Product Description
INSTI Test - Chikungunya - Product Status
INSTI Test - Chikungunya - Product Description
INSTI Test - Dengue - Product Status
INSTI Test - Dengue - Product Description
INSTI Test - Hepatitis C - Product Status
INSTI Test - Hepatitis C - Product Description
Zika/Flavivirus Test - Product Status
Zika/Flavivirus Test - Product Description
bioLytical Laboratories Inc, Key Employees
bioLytical Laboratories Inc, Other Locations
Glossary

★調査レポート[bioLytical Laboratories Inc:企業の製品パイプライン分析] (コード:GDME15380PD)販売に関する免責事項を必ずご確認ください。
★調査レポート[bioLytical Laboratories Inc:企業の製品パイプライン分析]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆